₹960 to ₹1,008 per equity share of the face value of ₹10. The Emcure Pharmaceuticals IPO date of subscription is scheduled for Wednesday, July 3, and will end on Friday, July 5.
The allocation to anchor investors for the Emcure Pharmaceuticals IPO is scheduled to take place on Tuesday, July 2.The floor price and the cap price are 96 times and 100.80 times the face value of the equity shares respectively. Bids can be made for a minimum of 14 equity shares and in multiples of 14 equity shares thereafter.
A discount of ₹90 per equity share is being offered to eligible employees bidding in the employee reservation portion. (more to come) Milestone Alert!
Livemint tops charts as the fastest growing news website in the world